The epidemiologic research of Fabry disease for hypertrophic cardiomyopathy in Yokohama.

The epidemiologic research of Fabry disease for hypertrophic cardiomyopathy in Yokohama. - The epidemiologic research of Fabry disease for hypertrophic cardiomyopathy in Yokohama.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015593

Enrollment

480

Registered

2014-11-04

Start date

2014-11-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fabry disease

Interventions

We take blood sample of 5ml for the patients.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Petients participate in this trial on their own will.

Exclusion criteria

Exclusion criteria: Patients can't participate in this trial on their own will, with dementia, et al.

Design outcomes

Primary

Measure	Time frame
1. Plasmma enzymatic activity of alpha-GAL A 2. Plasma globotriaosylsphingosine(Lyso-GB3)	—

Countries

Japan

Contacts

Public ContactMinako Kagimoto

Yokohama City University Graduate School of Medicine Medical Science and Cardiorenal Medicine

minako@yokohama-cu.ac.jp045-787-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026